A startup backed by Sam Altman and his husband is working on editing babies' genes, with the goal of removing faulty genes that cause hereditary diseases. The company's efforts are reportedly underway despite a US ban on genetically engineered babies. The project has raised concerns among scientists, who warn of the potential dangers of such gene editing.